MarketLens

What Did the Recent CARVYKTI Data Reveal About Its Potential

3 months ago

SHARE THIS ON:

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

What Did Legend Biotech's Investor Event Reveal About CARVYKTI

3 months ago

What Did Bunge's 2026 Investor Day Reveal About Its Future

6 months ago

What Did Skillsoft's Q4 FY2026 Earnings Reveal About Its Trajectory

5 months ago

What Do Summit Therapeutics' Q4 Results Reveal About Its Financial Health

6 months ago

Immatics: 'Buy' On Anzu-Cel 1st Half 2027 Catalyst And Potential Label Expansion For Uveal Melanoma

Immatics N.V. was downgraded to "Buy" from "Strong Buy" after a partial partnership termination, with its thesis hinging on anzu-cel phase 3 SUPRAME data in H1 2027. Phase 1b results showed 56% cORR a...

IMTX

Stock News•1 months ago

Legend Biotech: Why I'm Ready To Go Long Again

Carvykti sales rose 10.1% QoQ and 49.7% YoY to $657M in Q2, after J&J reported continued strong demand for the CAR-T therapy. Legend Biotech could beat consensus estimates when it reports Q2 results.

LEGN

Stock News•1 months ago

TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma

J&J's TECVAYLI + TALVEY cut disease progression/death risk by 89% and death risk by 62% in earlier-line RRMM, per Phase 3 MonumenTAL-6 trial results.

JNJ

Breaking News

Clinical Trials (Phase I, II, III)

Creator Economy

Crude Oil (WTI/Brent)

Top Headlines

View More →

Stock News•2 hours ago

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Stock News•2 hours ago

Viral AI Dommer Tweet: Engineered Panic?

Stock News•3 hours ago

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Stock News•4 hours ago

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Stock News•6 hours ago

What Did the Recent CARVYKTI Data Reveal About Its Potential

Exclusive Content for Pro Members

Related Articles

What Did Legend Biotech's Investor Event Reveal About CARVYKTI

What Did Bunge's 2026 Investor Day Reveal About Its Future

What Did Skillsoft's Q4 FY2026 Earnings Reveal About Its Trajectory

What Do Summit Therapeutics' Q4 Results Reveal About Its Financial Health

Category

You may also like

Immatics: 'Buy' On Anzu-Cel 1st Half 2027 Catalyst And Potential Label Expansion For Uveal Melanoma

Legend Biotech: Why I'm Ready To Go Long Again

TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma

Breaking News

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Top Headlines

Cybersecurity Is the Next Big Market for Artificial Intelligence (AI), According to Jensen Huang. This Super Stock-Split Stock Is the One to Own.

Viral AI Dommer Tweet: Engineered Panic?

Jeff Bezos Built Amazon Into a $1.8 Trillion Company. Here's How Andy Jassy Is Making It Worth Even More.

Apple Bought Back More Than $880 Billion of Its Own Stock During Tim Cook's 15 Years as CEO. Here's How That Reshaped Shareholder Returns.

Warren Buffett Made Apple Berkshire Hathaway's Single Largest Stock Position: $10,000 Invested 10 Years Ago Would Be Worth Roughly $122,400 Today